Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

J. P. Palmer; G. A. Fleming; C. J. Greenbaum; K. C. Herold; L. D. Jansa; H. Kolb; J. M. Lachin; K. S. Polonsky; P. Pozzilli; J. S. Skyler; M. W. Steffes

doi:10.2337/diabetes.53.7.1934

Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

J. P. Palmer, G. A. Fleming, C. J. Greenbaum, K. C. Herold, L. D. Jansa, H. Kolb, J. M. Lachin, K. S. Polonsky, P. Pozzilli, J. S. Skyler, M. W. Steffes

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1934
Number of pages	1
Journal	Diabetes
Volume	53
Issue number	7
DOIs	https://doi.org/10.2337/diabetes.53.7.1934
State	Published - Jul 2004
Externally published	Yes

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/diabetes.53.7.1934

Cite this

Palmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., & Steffes, M. W. (2004). Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)). Diabetes, 53(7), 1934. https://doi.org/10.2337/diabetes.53.7.1934

Erratum : C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)). / Palmer, J. P.; Fleming, G. A.; Greenbaum, C. J.; Herold, K. C.; Jansa, L. D.; Kolb, H.; Lachin, J. M.; Polonsky, K. S.; Pozzilli, P.; Skyler, J. S.; Steffes, M. W.

In: Diabetes, Vol. 53, No. 7, 07.2004, p. 1934.

Research output: Contribution to journal › Comment/debate › peer-review

Palmer, JP, Fleming, GA, Greenbaum, CJ, Herold, KC, Jansa, LD, Kolb, H, Lachin, JM, Polonsky, KS, Pozzilli, P, Skyler, JS & Steffes, MW 2004, 'Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))', Diabetes, vol. 53, no. 7, pp. 1934. https://doi.org/10.2337/diabetes.53.7.1934

Palmer, J. P. ; Fleming, G. A. ; Greenbaum, C. J. ; Herold, K. C. ; Jansa, L. D. ; Kolb, H. ; Lachin, J. M. ; Polonsky, K. S. ; Pozzilli, P. ; Skyler, J. S. ; Steffes, M. W. / Erratum : C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264)). In: Diabetes. 2004 ; Vol. 53, No. 7. pp. 1934.

@article{0d1574874c3143b3ab0769180a4d7c9e,

title = "Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))",

author = "Palmer, {J. P.} and Fleming, {G. A.} and Greenbaum, {C. J.} and Herold, {K. C.} and Jansa, {L. D.} and H. Kolb and Lachin, {J. M.} and Polonsky, {K. S.} and P. Pozzilli and Skyler, {J. S.} and Steffes, {M. W.}",

year = "2004",

month = jul,

doi = "10.2337/diabetes.53.7.1934",

language = "English (US)",

volume = "53",

pages = "1934",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association Inc.",

number = "7",

}

TY - JOUR

T1 - Erratum

T2 - C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

AU - Palmer, J. P.

AU - Fleming, G. A.

AU - Greenbaum, C. J.

AU - Herold, K. C.

AU - Jansa, L. D.

AU - Kolb, H.

AU - Lachin, J. M.

AU - Polonsky, K. S.

AU - Pozzilli, P.

AU - Skyler, J. S.

AU - Steffes, M. W.

PY - 2004/7

Y1 - 2004/7

UR - http://www.scopus.com/inward/record.url?scp=3042822067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042822067&partnerID=8YFLogxK

U2 - 10.2337/diabetes.53.7.1934

DO - 10.2337/diabetes.53.7.1934

M3 - Comment/debate

AN - SCOPUS:3042822067

VL - 53

SP - 1934

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 7

ER -

Erratum: C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function: Report of an ADA workshop, 21-22 October 2001 (Diabetes (2004) 53 (250-264))

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this